These results reveal that the molecular phenotypes of SRC-3 KO Tregs are very different in spleens versus tumors, and SRC-3 KO Tregs in breast tumors promote the antitumor environment by inducing expression of Ifng and other cytokines. The gene discussed is NCOA3; the disease is breast neoplasm.